STANDARD BIOTOOLS INC. — Director's Dealing 2022

Jun 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-05-31

Reporting Person: Khadder Nicholas (SVP, Gen. Counsel & Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-05-31	Common Stock	A	3341	$1.607	Acquired	100480	Direct

Footnotes

F1: These shares were acquired under the Standard BioTools 2017 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).